Symrise launches Cellexora MD: plant‑derived exosomes for skin regeneration

Key highlights
  • Symrise will present Cellexora MD at in-cosmetics Global 2026 (Apr 14-16, Paris).
  • INCI: Maltodextrin, Malus domestica fruit vesicles sourced from upcycled organic Italian apple side streams in Italy.
  • Clinical data report reductions in wrinkle length, depth and volume within 30 days.
  • Produced to ISO 16128-2 as a 100% natural-origin, water-soluble white powder for broad formulation compatibility.

Product overview

Cellexora™ MD is a cosmetic ingredient based on true plant-derived extracellular vesicles (exosomes) produced as a white, odorless powder (INCI: Maltodextrin, Malus domestica fruit vesicles) intended to support skin regeneration and long-term vitality.

Source and manufacturing

The material is upcycled from organic Italian apple side streams via a clean, traceable process and produced to ISO 16128-2 as 100% natural-origin content; the company reports high stability and reproducibility.

Mechanism and measured effects

The vesicles act as biological messengers interacting with keratinocytes, fibroblasts and macrophages; cited clinical data show reductions in wrinkle length, depth and volume within 30 days and indicate support for collagen production and soothing pathways.

Formulation and industry presentation

High water solubility provides formulation flexibility for broad skincare applications; the ingredient will be presented at in-cosmetics Global 2026 (April 14–16, Paris, Stand 3E10).